1. Home
  2. WLK vs PEN Comparison

WLK vs PEN Comparison

Compare WLK & PEN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Westlake Corporation

WLK

Westlake Corporation

HOLD

Current Price

$67.75

Market Cap

7.5B

Sector

Industrials

ML Signal

HOLD

Logo Penumbra Inc.

PEN

Penumbra Inc.

HOLD

Current Price

$299.66

Market Cap

10.9B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
WLK
PEN
Founded
1986
2004
Country
United States
United States
Employees
N/A
N/A
Industry
Major Chemicals
Medical/Dental Instruments
Sector
Industrials
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
7.5B
10.9B
IPO Year
2004
2015

Fundamental Metrics

Financial Performance
Metric
WLK
PEN
Price
$67.75
$299.66
Analyst Decision
Buy
Strong Buy
Analyst Count
15
16
Target Price
$88.00
$307.19
AVG Volume (30 Days)
1.6M
479.9K
Earning Date
10-30-2025
11-05-2025
Dividend Yield
3.12%
N/A
EPS Growth
N/A
367.34
EPS
N/A
4.14
Revenue
$11,480,000,000.00
$1,333,798,000.00
Revenue This Year
N/A
$16.77
Revenue Next Year
$3.18
$14.12
P/E Ratio
N/A
$72.65
Revenue Growth
N/A
14.61
52 Week Low
$56.33
$221.26
52 Week High
$128.85
$310.00

Technical Indicators

Market Signals
Indicator
WLK
PEN
Relative Strength Index (RSI) 53.80 67.77
Support Level $56.33 $284.95
Resistance Level $70.31 $298.69
Average True Range (ATR) 2.88 8.02
MACD 1.42 0.11
Stochastic Oscillator 83.23 91.50

Price Performance

Historical Comparison
WLK
PEN

About WLK Westlake Corporation

Westlake Corp is a manufacturer and supplier of chemicals, polymers, and building products. Its Performance and Essential Materials segment offers a wide range of essential building blocks for making products utilized in everyday living, including olefins, vinyl chemicals, polyethylene, and epoxies. Its Housing and Infrastructure Products segment produces key finished goods for building products, pipe and fittings, and global compounds businesses.

About PEN Penumbra Inc.

Domiciled in the US, Penumbra designs, manufactures, and markets an array of thrombectomy and embolization devices and equipment to mechanically remove blood clots. The firm sells mainly to hospitals and physicians. These minimally invasive devices are primarily used in the acute care setting for patients with stroke, pulmonary embolism, deep vein thrombosis, cranial aneurysms, and other vascular diseases.

Share on Social Networks: